# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-26-014001
Filing Date
2026-03-31
Accepted
2026-03-31 14:02:37
Documents
73
Period of Report
2025-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | form10-k.htm iXBRL | 10-K | 1651503
2 | EX-3.2 | ex3-2.htm | EX-3.2 | 172099
3 | EX-10.17 | ex10-17.htm | EX-10.17 | 149251
4 | EX-10.19 | ex10-19.htm | EX-10.19 | 78431
5 | EX-21.1 | ex21-1.htm | EX-21.1 | 3658
6 | EX-23.1 | ex23-1.htm | EX-23.1 | 5548
7 | EX-31.1 | ex31-1.htm | EX-31.1 | 14839
8 | EX-31.2 | ex31-2.htm | EX-31.2 | 15091
9 | EX-32.1 | ex32-1.htm | EX-32.1 | 7439
10 | EX-32.2 | ex32-2.htm | EX-32.2 | 4824
11 | GRAPHIC | report_001.jpg | GRAPHIC | 8043
| Complete submission text file | 0001493152-26-014001.txt |  | 6543135

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
12 | XBRL SCHEMA FILE | mira-20251231.xsd | EX-101.SCH | 36472
13 | XBRL CALCULATION FILE | mira-20251231_cal.xml | EX-101.CAL | 54861
14 | XBRL DEFINITION FILE | mira-20251231_def.xml | EX-101.DEF | 156913
15 | XBRL LABEL FILE | mira-20251231_lab.xml | EX-101.LAB | 381664
16 | XBRL PRESENTATION FILE | mira-20251231_pre.xml | EX-101.PRE | 307047
76 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-k_htm.xml | XML | 669689

Mailing Address 324 SOUTH HYDE PARK AVENUE, SUITE 350 TAMPA FL 33606
Business Address 1200 BRICKELL AVENUE SUITE 1950 #1183 MIAMI FL 33131 813-369-5150
MIRA PHARMACEUTICALS, INC. (Filer) CIK: 0001904286 (see all company filings)

EIN.: 853354547 | State of Incorp.: FL
Type: 10-K | Act: 34 | File No.: 001-41765 | Film No.: 26820360
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)